McKesson Slides as $0.59 Billion Volume Ranks 216th Amid Healthcare Sector Pressures

McKesson (MCK) closed 0.97% lower on October 1, 2025, with a trading volume of $0.59 billion, ranking 216th in market activity for the day. The stock's performance reflects ongoing sector-specific pressures amid evolving healthcare distribution dynamics.

Recent market analysis indicates mixed investor sentiment toward the pharmacy benefits manager. While industry observers highlight potential cost-saving initiatives in drug procurement, concerns persist regarding regulatory scrutiny and margin compression in specialty pharmacy services. Analysts note that MCK's valuation multiples remain anchored to broader healthcare sector trends, with limited near-term catalysts identified in operational metrics.

Backtesting parameters for a volume-based trading strategy require confirmation of key execution details. The proposed methodology involves daily selection of the 500 highest-volume NYSE/NASDAQ-listed stocks, equally weighted, with positions held overnight. Transaction costs and benchmark selection (defaulting to SPY) remain pending finalization before historical performance evaluation can commence.

To run this back-test accurately, clarification is needed on three core aspects: 1) Stock universe scope (full exchange listings vs. S&P 1500 focus), 2) Portfolio construction rules (equal weighting enforcement and turnover assumptions), and 3) Benchmark selection (SPY confirmation). Once parameters are confirmed, the back-test will generate daily trading signals from January 3, 2022, through the most recent market close.